Stay updated on Pembrolizumab in EOC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in EOC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in EOC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Fallopian tube cancer added as a condition and the page updated to version 3.4.2; the government funding status notice has been removed.
    Difference
    0.5%
    Check dated 2026-02-11T14:22:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide government funding/status notice was added and the page version updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:57.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a Show glossary control and updated metadata labels, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision to v3.4.0 (from v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:29:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.4 updates the page revision label (replacing v3.3.3). This change does not affect any study data or content presented on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:59:00.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a Locations section with Florida as a location and removed the separate Florida Locations entry; the HHS Vulnerability Disclosure link was removed. Revision tag updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:34:59.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision information updated from v3.3.1 to v3.3.2 in the page footer, with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:45:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in EOC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in EOC Clinical Trial page.